Bespoke Extracts, Inc.
Bespoke Extracts, Inc. (BSPK): 7 pipeline candidates · ~11 mo cash runway · 1 clinical trial. Updated within the last hour.
BioSniper Score
3-factor signal · derived from public data
10.8 months
D/E -1.11 · 0% dilution
N/A
7 candidates
N/A
N/A
A transparent, data-derived signal for Bespoke Extracts, Inc.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$1.7M
Cash
$17K
Quarterly Burn
$20K
Runway
10.8 mo
Revenue
$468K
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Pipeline (7 candidates)
Frequently asked questions
How many drug candidates are in Bespoke Extracts, Inc.'s pipeline?
Bespoke Extracts, Inc. (BSPK) has 7 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.
What is Bespoke Extracts, Inc.'s cash runway?
Based on its most recent reported cash balance and quarterly burn rate, Bespoke Extracts, Inc. has approximately 10.8 months of cash runway.
What is Bespoke Extracts, Inc.'s market capitalization?
Bespoke Extracts, Inc.'s market capitalization is approximately $1.7M.
Who is the CEO of Bespoke Extracts, Inc.?
Mr. Michael R. Feinsod J.D. is the chief executive officer of Bespoke Extracts, Inc. (BSPK).
Get the full picture on Bespoke Extracts, Inc.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.